Clearance Summary
VOLU-SOL HARRIS HEMATOXYLIN received FDA 510(k) clearance under submission number K800324, sponsored by Volu Sol Medical Industries. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1980-02-22.
- Submission: K800324
- Applicant / Sponsor: Volu Sol Medical Industries
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class I
- Regulation citation: 21 CFR 864.1850
- Decision date: 1980-02-22
Classification & Regulation
This clearance is catalogued under FDA product code HYK and 21 CFR 864.1850, within the Hematology review panel as a Class I device.